Zhong Bin-Yan, Abiola Godwin, Weiss Clifford R
Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, China.
Division of Interventional Radiology, Department of Radiology and Radiologic Science, Johns Hopkins School of Medicine, Sheikh Zayed Tower, Suite 7203, 1800 Orleans St, Baltimore, MD, USA.
Cardiovasc Intervent Radiol. 2018 Nov;41(11):1639-1647. doi: 10.1007/s00270-018-1996-y. Epub 2018 Jun 5.
Obesity is a worldwide public health epidemic that leads to increased morbidity, mortality, and cost burden to health care. Although bariatric surgery has been recognized as a standard invasive treatment for obesity, it is accompanied by relatively high morbidity and cost burden, as well as limited treatment outcome. Therefore, alternative treatments with lower morbidity and cost for surgery that target patients who are obese, but not morbidly obese, are needed. A minimally invasive trans-catheter procedure, named bariatric arterial embolization or bariatric embolization (BAE), has been identified as a potential solution, based on its safety and preliminary efficacy profiles. The purpose of this review is to introduce up-to-date clinical data and discuss future directions for BAE for the treatment of obesity.
肥胖是一种全球性的公共卫生流行病，会导致发病率、死亡率上升以及医疗保健成本负担加重。尽管减肥手术已被公认为肥胖的标准侵入性治疗方法，但它伴随着相对较高的发病率和成本负担，以及有限的治疗效果。因此，需要针对肥胖但非病态肥胖患者的发病率和成本较低的替代手术治疗方法。一种名为减肥动脉栓塞术或减肥栓塞术（BAE）的微创经导管手术，基于其安全性和初步疗效已被视为一种潜在的解决方案。本综述的目的是介绍最新的临床数据，并讨论BAE治疗肥胖的未来方向。
